Serial Biomarker Measurements in Ambulatory Patients With Chronic Heart Failure | Zendy

Wayne L. Miller | Zendy; Karen Hartman | Zendy; Mary F. Burritt | Zendy; Diane E. Grill | Zendy; Richard J. Rodeheffer | Zendy; John C. Burnett | Zendy; Allan S. Jaffe | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serial Biomarker Measurements in Ambulatory Patients With Chronic Heart Failure

Author(s) -

Wayne L. Miller,

Karen Hartman,

Mary F. Burritt,

Diane E. Grill,

Richard J. Rodeheffer,

John C. Burnett,

Allan S. Jaffe

Publication year - 2007

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.107.694562

Subject(s) - medicine , hazard ratio , heart failure , cardiology , natriuretic peptide , troponin complex , troponin t , ambulatory , population , cohort , biomarker , troponin , confidence interval , myocardial infarction , biochemistry , chemistry , environmental health

Cardiac troponin T (cTnT) and B-type natriuretic peptide (BNP) have been used to estimate prognosis in heart failure; however, most studies have evaluated decompensated patients with single measurements. To determine if there are advantages to serial measurements, we evaluated stable chronic heart failure patients every 3 months for 2 years.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research